Publications by authors named "Karl Technau"

Claim this Profile
A
Adolescent retention in HIV care within differentiated service-delivery models in sub-Saharan Africa.
Mhairi Maskew, Karl Technau, Mary-Ann Davies, Rachel Vreeman, Matthew P Fox

Lancet HIV· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early infant diagnosis HIV-1 PCR cycle-threshold predicts infant viral load at birth.
Ahmad Haeri Mazanderani, Tendesayi Kufa, Karl G Technau, Renate Strehlau, Faeezah Patel

J Clin Virol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Should We Do When HIV-positive Children Fail First-line Combination Antiretroviral Therapy? A Comparison of 4 ART Management Strategies.
Gabriela Patten, Michael Schomaker, Mary-Ann Davies, Helena Rabie, Gert van Zyl, Karl Technau

Pediatr Infect Dis J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lamivudine monotherapy as a holding regimen for HIV-positive children.
Gabriela Patten, Jonathan Bernheimer, Lee Fairlie, Helena Rabie, Shobna Sawry, Karl Technau

PLoS One· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Field Performance and Diagnostic Accuracy of a Low-Cost Instrument-Free Point-of-Care CD4 Test (Visitect CD4) Performed by Different Health Worker Cadres among Pregnant Women.
Stanley Luchters, Karl Technau, Yasmin Mohamed, Matthew F Chersich, Paul A Agius

J Clin Microbiol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into Adherence among a Cohort of Adolescents Aged 12-20 Years in South Africa: Reported Barriers to Antiretroviral Treatment.
Mhairi Maskew, Matthew P Fox, Denise Evans, Darshini Govindasamy, Lise Jamieson, Karl Technau

AIDS Res Treat· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Y
Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.
Louise Kuhn, Diana B Schramm, Stephanie Shiau, Renate Strehlau, Francoise Pinillos, Karl Technau

AIDS· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral load versus CD4⁺ monitoring and 5-year outcomes of antiretroviral therapy in HIV-positive children in Southern Africa: a cohort-based modelling study.
Luisa Salazar-Vizcaya, Olivia Keiser, Karl Technau, Mary-Ann Davies, Andreas D Haas

AIDS· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA Collaboration.
Mary-Ann Davies, Sam Phiri, Robin Wood, Maureen Wellington, Vivian Cox, Karl Technau

PLoS One· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
Michael Schomaker, Matthias Egger, James Ndirangu, Sam Phiri, Harry Moultrie, Karl Technau

PLoS Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paradoxical Mycobacterium tuberculosis meningitis immune reconstitution inflammatory syndrome in an HIV-infected child.
Emma Kalk, Karl Technau, Willy Hendson, Ashraf Coovadia

Pediatr Infect Dis J· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost and outcomes of paediatric antiretroviral treatment in South Africa.
Gesine Meyer-Rath, Alana Brennan, Lawrence Long, Buyiswa Ndibongo, Karl Technau

AIDS· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
Mary-Ann Davies, Andrew Boulle, Karl Technau, Brian Eley, Harry Moultrie

Trop Med Int Health· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variability of growth in children starting antiretroviral treatment in southern Africa.
Thomas Gsponer, Ralf Weigel, Mary-Ann Davies, Carolyn Bolton, Harry Moultrie, Karl Technau

Pediatrics· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early diagnosis of in utero and intrapartum HIV infection in infants prior to 6 weeks of age.
Rivka R Lilian, Emma Kalk, Kapila Bhowan, Leigh Berrie, Sergio Carmona, Karl Technau

J Clin Microbiol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of immunological criteria for identifying virological failure in children on antiretroviral therapy - the IeDEA Southern Africa Collaboration.
Mary-Ann Davies, Andrew Boulle, Brian Eley, Harry Moultrie, Karl Technau

Trop Med Int Health· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic failure and second-line antiretroviral therapy in children in South Africa--the IeDEA Southern Africa collaboration.
Mary-Ann Davies, Harry Moultrie, Brian Eley, Helena Rabie, Gilles Van Cutsem, Karl Technau

J Acquir Immune Defic Syndr· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mortality and loss to follow-up in HIV-infected children starting antiretroviral therapy in Southern Africa.
Lukas Fenner, Martin W G Brinkhof, Olivia Keiser, Ralf Weigel, Morna Cornell, Karl Technau

J Acquir Immune Defic Syndr· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of highly active antiretroviral therapy duration and regimen on risk for mother-to-child transmission of HIV in Johannesburg, South Africa.
Risa M Hoffman, Vivian Black, Karl Technau, Karin Joan van der Merwe, Judith Currier

J Acquir Immune Defic Syndr· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.
Mary-Ann Davies, Olivia Keiser, Karl Technau, Brian Eley, Helena Rabie

S Afr Med J· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration.
Morna Cornell, Karl Technau, Lara Fairall, Robin Wood, Harry Moultrie

S Afr Med J· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa.
Karin van der Merwe, Matthew F Chersich, Karl Technau, Yvonne Umurungi, Francesca Conradie

J Acquir Immune Defic Syndr· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis